Should the drug regulatory agencies take into consideration drug development input directly from study participants all the way through its review of (new/generic) fillings?

Yes / No share your comments .

Emina Muminović Technician Asked on February 7, 2015 in Drugs.
Add Comment
0 Answer(s)

Your Answer

By posting your answer, you agree to the privacy policy and terms of service.